Drorit Attias

Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience

Ari Zimran, Gheona Altarescu, Mici Philips et al. · Blood · 2010 · 133 citations · Full text

Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement

Deborah Elstein, Altoon Dweck, Drorit Attias et al. · Blood · 2007 · 124 citations

Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model

Ori Rogowski, Itzhak Shapira, Ari Zimran et al. · Blood Cells Molecules and Diseases · 2004 · 32 citations

Inflammation, Disease Diagnosis, Autoimmune Disease +14

Effect of ozone on neutrophil function <i>in vitro</i>

Maya Margalit, Eyal Attias, Drorit Attias et al. · Clinical & Laboratory Haematology · 2001 · 31 citations

Inflammation, Asthma, Therapeutic Effect +11

Assessment of the Clinical Significance of Production of Extended-spectrum β-Lactamases (ESBL) by Enterobacteriaceae

Ruth Henshke‐Bar‐Meir, Amos M. Yinnon, Bernard Rudensky et al. · Infection · 2006 · 26 citations

Extended-spectrum β-Lactamases, Antimicrobial Susceptibility, Antimicrobial Resistance Gene +8